Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

clinical trial

Details

Instance of: clinical trial
Start time: 11 July 2008
Country: United States
Main subject: hepatitis, hepatitis C, hepatitis A
clinical trial phase: phase I clinical trial
minimum age: 18
number of participants: 81
research intervention: ribavirin
research site: United States National Institutes of Health
sponsor: National Institute of Diabetes and Digestive and Kidney Diseases
study type: interventional study
title: Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Nothing in the MetaHistoryBook collection references this item yet.